Viewing StudyNCT02681861



Ignite Creation Date: 2024-05-06 @ 8:11 AM
Last Modification Date: 2024-10-26 @ 11:57 AM
Study NCT ID: NCT02681861
Status: COMPLETED
Last Update Posted: 2017-01-10
First Post: 2016-01-21

Brief Title: A Study to Assess the Safety Tolerability Pharmacokinetics and Pharmacodynamics of ASP6294 Administered Intravenously or Subcutaneously in Healthy Young Male and Female Subjects
Sponsor: Astellas Pharma Europe BV
Organization: Astellas Pharma Inc

Conditions & Keywords Data

Conditions:
Name
Pharmacokinetics of ASP6294
Healthy Subjects
Keywords:
Name View
Healthy subjects View
Pharmacodynamics View
Pharmacokinetics View
ASP6294 View
Maximum tolerated dose View